Hurst Daniel J, Bobier Christopher A
Department of Family Medicine, Rowan-Virtua School of Osteopathic Medicine, Stratford, New Jersey, USA.
Foundational Sciences, Central Michigan University College of Medicine, Mount Pleasant, Michigan, USA.
Appl Biosaf. 2025 Jun 5;30(2):97-106. doi: 10.1089/apb.2024.0034. eCollection 2025 Jun.
Dual-use research (DUR) describes research with potential benefits that could be misapplied for harm. Policy on DUR is often limited to life sciences research. However, recently, there have been demonstrations of how research with dual-use concerns may extend beyond the life sciences to artificial intelligence (AI). One method of ensuring that research with dual-use concerns is not misapplied for harm is by censoring scientific journal articles. Journals may have policy on managing article submissions with potential DUR concerns. This study compared the policies of life science and AI journals toward DUR.
Google Scholar Metrics and Scimago Journal and Country Rank were utilized to identify and select the top 20 publications in fields of life sciences and AI by specific metrics. The publicly accessible websites of each journal were searched to ascertain their publication policies regarding DUR. Journals and/or publishers were contacted if no policy was located.
From Google Scholar, 12/20 journals within the "Life Sciences & Earth Sciences" category had policies on DUR; from Scimago, 9/16 of the "Biochemistry, Genetics, and Molecular Biology" category had policies; and 8/19 of the "Immunology and Microbiology" category had policies. For AI journals, 2/13 journals from Google Scholar had policies; 4/15 journals from Scimago had policies.
More journals in the life sciences have extant policies on how to handle article submissions with DUR concerns. Very few AI journals have policies.
两用研究（DUR）是指具有潜在益处但可能被误用造成危害的研究。两用研究政策通常仅限于生命科学研究。然而，最近有证据表明，涉及两用问题的研究可能从生命科学扩展到人工智能（AI）。确保涉及两用问题的研究不被误用造成危害的一种方法是审查科学期刊文章。期刊可能有关于管理存在潜在两用问题的文章投稿的政策。本研究比较了生命科学期刊和人工智能期刊针对两用研究的政策。
利用谷歌学术指标和Scimago期刊与国家排名，通过特定指标识别并选出生命科学和人工智能领域的前20种出版物。搜索每种期刊可公开访问的网站，以确定其关于两用研究的出版政策。如果未找到政策，则联系期刊和/或出版商。
在谷歌学术中，“生命科学与地球科学”类别下的20种期刊中有12种有两用研究政策；在Scimago中，“生物化学、遗传学和分子生物学”类别的16种期刊中有9种有政策；“免疫学和微生物学”类别的19种期刊中有8种有政策。对于人工智能期刊，谷歌学术中的13种期刊中有2种有政策；Scimago中的15种期刊中有4种有政策。
更多生命科学期刊有关于如何处理存在两用问题的文章投稿的现有政策。极少有人工智能期刊有此类政策。
